17 October 2017
News and Views
Links and Services
The latest Alimentary Pharmacology & Therapeutics evaluates studies that de-escalate therapy in IBD.
Therapeutic objectives are currently evolving in inflammatory bowel diseases (IBD) from control o
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors